Etid klinik pou Kansè po nan New Jersey
6 etid pou Kansè po ap chèche patisipan nan sit nan New Jersey.
Vil nan New Jersey
Tèks ofisyèl etid la (Anglè)
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- MD Anderson Cancer Center at Cooper, Camden
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT05727904A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT05859074Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
- Hackensack University Medical Center, Hackensack
- Atlantic Health System, Morristown
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Apr 17, 2026 · NCT06947928A Mobile Health Intervention Among Hispanics
- Rutgers Cancer Institute of New Jersey, New Brunswick
Ap rekriteVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Dec 16, 2025 · NCT05389332SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Brunswick
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774Naltrexone and Propranolol Combined With Immunotherapy
- Rutgers Cancer Institute of New Jersey, New Brunswick
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2025 · NCT05968690Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.